FDAnews Announces -- Dealing with FDA and Their Inspection Enforcement Tools Webinar, April 23, 2019
Warning letters are on the rise. Former FDAer provides insights on responding to FDA enforcement actions. Find out more here…
FALLS CHURCH, Va., April 09, 2019 /PRNewswire-PRWeb/ -- Dealing with FDA and Their Inspection Enforcement Tools
**An FDAnews Webinar**
Tuesday, April 23, 2019, 1:30 p.m. - 3:00 p.m. EDT
https://www.fdanews.com/inspectionenforcementtools
What's the best way to proceed after an inspectional observation?
John Fuson — Partner, Crowell & Moring, LLP and former Associate Chief Counsel for Enforcement, FDA — will review factors that increase enforcement risks and provide insights on how enforcement progresses from inspectional observations to 483s, warning letters, seizures, injunctions and possible criminal actions or jail time.
Join our upcoming webinar and become equipped with:
- Best practices for answering FDA Form 483 observations
- Strategies for avoiding warning letters and serious enforcement actions
- Tips for building agency confidence in site operations
- Tools for assessing company exposure to regulatory risk — including identifying hot-button issues for inspections
- Knowledge of FDA factors that renders enforcement or escalations
Avoid escalation to injunctions by knowing how to respond to FDA enforcement actions. Visit our website for more information about the speaker, pricing, and more.
Interested in registering multiple sites?
Call (888) 838-5578 in the U.S. or +1 (703) 538-7600 globally
to learn about our special multisite discount.
Webinar Details:
Dealing with FDA and Their Inspection Enforcement Tools
**An FDAnews Webinar**
Tuesday, April 23, 2019, 1:30 p.m. - 3:00 p.m. EDT
https://www.fdanews.com/inspectionenforcementtools
Tuition:
$287 per site
Easy Ways to Register:
Online: https://www.fdanews.com/inspectionenforcementtools?hittrk=19409VOCUS [https://www.fdanews.com/inspectionenforcementtools __title__ Inspections Enforcement]
By phone: 888-838-5578 or 703-538-7600
About FDAnews:
FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews' print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA's complex and ever-changing regulations.
SOURCE FDANEWS
Share this article